123 related articles for article (PubMed ID: 15300806)
1. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
[TBL] [Abstract][Full Text] [Related]
2. Uroplakin gene expression by normal and neoplastic human urothelium.
Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
[TBL] [Abstract][Full Text] [Related]
3. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells.
Wu XR; Medina JJ; Sun TT
J Biol Chem; 1995 Dec; 270(50):29752-9. PubMed ID: 8530366
[TBL] [Abstract][Full Text] [Related]
4. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
5. Formation of asymmetric unit membrane during urothelial differentiation.
Sun TT; Zhao H; Provet J; Aebi U; Wu XR
Mol Biol Rep; 1996; 23(1):3-11. PubMed ID: 8983014
[TBL] [Abstract][Full Text] [Related]
6. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
[TBL] [Abstract][Full Text] [Related]
7. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.
Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341
[TBL] [Abstract][Full Text] [Related]
8. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
9. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.
Tu L; Sun TT; Kreibich G
Mol Biol Cell; 2002 Dec; 13(12):4221-30. PubMed ID: 12475947
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of four uroplakins in urothelial preneoplastic lesions.
Zupančič D; Zakrajšek M; Zhou G; Romih R
Histochem Cell Biol; 2011 Oct; 136(4):491-500. PubMed ID: 21853341
[TBL] [Abstract][Full Text] [Related]
12. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
13. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia.
Xie B; Zhou G; Chan SY; Shapiro E; Kong XP; Wu XR; Sun TT; Costello CE
J Biol Chem; 2006 May; 281(21):14644-53. PubMed ID: 16567801
[TBL] [Abstract][Full Text] [Related]
14. Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: implications for uroplakin structure and function.
Garcia-España A; Chung PJ; Zhao X; Lee A; Pellicer A; Yu J; Sun TT; Desalle R
Mol Phylogenet Evol; 2006 Nov; 41(2):355-67. PubMed ID: 16814572
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupančič D; Ovčak Z; Vidmar G; Romih R
Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
[TBL] [Abstract][Full Text] [Related]
16. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease.
Stahlschmidt J; Varley CL; Toogood G; Selby PJ; Southgate J
Kidney Int; 2005 Sep; 68(3):1032-40. PubMed ID: 16105033
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
[TBL] [Abstract][Full Text] [Related]
18. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
[TBL] [Abstract][Full Text] [Related]
19. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition.
Liang FX; Riedel I; Deng FM; Zhou G; Xu C; Wu XR; Kong XP; Moll R; Sun TT
Biochem J; 2001 Apr; 355(Pt 1):13-8. PubMed ID: 11256943
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
